AQX-27567-23451 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-04
Dose 1 — Janssen/Johnson & Johnson
2021-05-08
Registered in v-safe
2021-05-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-05-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-11-02
Survey response — 6 months, dose 1
MedDRA: Anosmia, Dizziness, Fatigue — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Extreme lightheaded ness and exhaustion. Loss of smell.

MedDRA releases: 2024-11 · check-in free text available
2021-11-02
Report sent to call center — 6 months, dose 1
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2021-11-03
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-04	Janssen/Johnson & Johnson

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — 6 months, dose 1

2021-11-02

Symptoms: Extreme lightheaded ness and exhaustion. Loss of smell.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Anosmia	·	·	✓
SD	Dizziness	·	·	✓
SD	Fatigue	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release